Lukasz Polanski

Lukasz Polanski

Auto-generated profile, based on publicly available information

Lukasz Polanski

Division of Child Health, Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
LPLukasz T. Polanski
Lukasz T. Polanski
MBMiriam N. Baumgarten
Miriam N. Baumgarten
SQSiobhan Quenby
Siobhan Quenby
JBJan Brosens
Jan Brosens
BCBruce K. Campbell
Bruce K. Campbell
NRNicholas J. Raine-Fenning
Nicholas J. Raine-Fenning

21 October 2017 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
MPMatthew Prior
Matthew Prior
ARA. Richardson
A. Richardson
SAS. Asif
S. Asif
LPL. Polanski
L. Polanski
MPM. Parris‐Larkin
M. Parris‐Larkin
NRN. J. Raine‐Fenning
N. J. Raine‐Fenning
Objectives: To assess the prevalence of congenital uterine anomalies, including arcuate uterus, and their effect on reproductive outcome in subfertile women undergoing assisted reproduction.Methods: Consecutive women referred for subfertility between May 2009 and November 2015 who underwent assisted reproduction were included in the study. As part of the initial assessment, each woman underwent three‐dimensional transvaginal sonography. Uterine morphology was classified using the modified American Fertility Society (AFS) classification of congenital uterine anomalies proposed by Salim et al. If the external contour of the uterus was uniformly convex or had an indentation of < 10 mm, but there was a cavity indentation, it was defined as arcuate or septate. Arcuate uterus was further defined as the presence of a concave fundal indentation with a central point of indentation at an obtuse angle. Subseptate uterus was defined as the presence of a septum, not extending to the cervix, with the central point of the septum at an acute angle; if the septum extended to the internal cervical os, the uterus was defined as septate. Reproductive outcomes, including live birth, clinical pregnancy and preterm birth, were compared between women with a normal uterus and those with a congenital uterine anomaly. Subgroup analysis by type of uterine morphology and logistic regression analysis adjusted for age, body mass index, levels of anti‐Müllerian hormone, antral follicle count and number and day of embryo transfer were performed.Results: A total of 2375 women were included in the study, of whom 1943 (81.8%) had a normal uterus and 432 (18.2%) had a congenital uterine anomaly. The most common anomalies were arcuate (n = 387 (16.3%)) and subseptate (n = 16 (0.7%)) uterus. The rate of live birth was similar between women with a uterine anomaly and those with a normal uterus (35% vs 37%; P = 0.47). The rates of clinical pregnancy, mode of delivery and sex of the newborn were also similar between the two groups. Preterm birth before 37 weeks' gestation was more common in women with uterine anomalies than in controls (22% vs 14%, respectively; P = 0.03). Subgroup analysis by type of anomaly showed no difference in the incidence of live birth and clinical pregnancy for women with an arcuate uterus, but indicated worse pregnancy outcome in women with other major anomalies (P = 0.042 and 0.048, respectively).Conclusions: Congenital uterine anomalies as a whole, when defined using the modified AFS classification, do not affect clinical pregnancy or live‐birth rates in women following assisted reproduction, but do increase the incidence of preterm birth. The presence of uterine abnormalities more severe than arcuate uterus significantly worsens all pregnancy outcomes. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

20 November 2013 in Human Reproduction
Verified
Journal Article
Open access
PDF file
LPL. T. Polanski
L. T. Polanski
MBM. A. P. Barbosa
M. A. P. Barbosa
WMW. P. Martins
W. P. Martins
MBM. N. Baumgarten
M. N. Baumgarten
BCB. Campbell
B. Campbell
NRN. Raine-Fenning
N. Raine-Fenning
Is there any scientific evidence to support the routine use of adjuvant therapies for women with elevated natural killer (NK) cells undergoing assisted reproduction techniques (ARTs) in order to improve live birth rate? Due to the poor quality evidence, this review does not support the use of described adjuvant treatments in women found to have elevated absolute numbers or activity of NK cells undergoing ART. Deregulation in the numbers of NK cells and/or their activity, in the blood as well as in the endometrium, has been associated with various manifestations of reproductive failure. NK cell analysis is becoming increasingly popular as a test offered to investigate the causes of reproductive failure. Adjuvant therapies influencing the NK cells have been postulated as therapeutic options for couples where deregulation of this component of the maternal immune system is suspected as the cause of infertility or implantation failure. Systematic review. Embase, LILACS, MEDLINE, PsycINFO, CENTRAL and CINAHL databases from 1946 to present were searched with no language restrictions. Studies evaluating the use of adjuvant therapies in women undergoing ART where NK cell numbers and/or activity were assessed were considered eligible for inclusion. Only three studies (one in abstract form only) meeting the inclusion criteria were identified: two reported the use of intravenous immunoglobulins (IVIg) and one the use of oral prednisolone. All studies demonstrated a beneficial effect of the interventions on clinical pregnancy rates with a risk ratio (RR) of 1.63 [95% confidence interval (CI) 1.00–2.66] for prednisolone and 3.41 (95%CI 1.90–6.11) for IVIg. Studies assessing the efficacy of IVIg have also reported live birth rate with an RR of 3.94 (95% CI 2.01–7.69) favoring the intervention. Data heterogeneity was substantial however (I2 = 66%) suggesting a cautious interpretation of the results. Differing study populations, lack of statistical power, method of data presentation (per couple or per cycle), the use of additional medications and differing dosage regimes contribute to data heterogeneity and suggest a cautious approach to data interpretation. This review identified some data showing that adjuvant therapies (mainly IVIg) in this selected population seem to confer some benefit on ART outcome. However, overall, the review does not support the use of prednisolone, IVIg or any other adjuvant treatment in women undergoing ART who are found to have elevated absolute numbers or activity of NK cells, purely due to the paucity of, or poor quality of, the evidence. Agreement as to the most reliable NK cell testing method must be made by the scientific community as well as ‘normal’ NK cell levels unequivocally defined. Well designed, sufficiently powered RCTs with an appropriate population selection and using the same NK cell testing methodology are required to ascertain the actual benefit of using adjuvant therapy treatment for elevated NK cell levels or activity in the context of pregnancy outcome following IVF. None.

18 April 2017 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
RDRuban Rex Peter Durairaj
Ruban Rex Peter Durairaj
AAAsma Aberkane
Asma Aberkane
LPLukasz Polanski
Lukasz Polanski
YMYojiro Maruyama
Yojiro Maruyama
MBMiriam Baumgarten
Miriam Baumgarten
YLYie Hou Lee
Yie Hou Lee
Is implantation failure following ART associated with a perturbed decidual response in endometrial stromal cells (EnSCs)? Dynamic changes in the secretome of decidualizing EnSCs underpin the transition of a hostile to a supportive endometrial microenvironment for embryo implantation; perturbation in this transitional pathway prior to ART is associated with implantation failure. Implantation is the rate-limiting step in ART, although the contribution of an aberrant endometrial microenvironment in IVF failure remains ill defined. In vitro characterization of the temporal changes in the decidual response of primary EnSCs isolated prior to a successful or failed ART cycle. An analysis of embryo responses to secreted cues from undifferentiated and decidualizing EnSCs was performed. The primary clinical outcome of the study was a positive urinary pregnancy test 14 days after embryo transfer. Primary EnSCs were isolated from endometrial biopsies obtained prior to IVF treatment and cryopreserved. EnSCs from 10 pregnant and 10 non-pregnant patients were then thawed, expanded in culture, subjected to clonogenic assays, and decidualized for either 2 or 8 days. Transcript levels of decidual marker gene [prolactin (PRL), insulin-like growth factor binding protein 1 (IGFBP1) and 11β-hydroxysteroid dehydrogenase (HSD11B1)] were analysed using real-time quantitative PCR and temporal secretome changes of 45 cytokines, chemokines and growth factors were measured by multiplex suspension bead immunoassay. The impact of the EnSC secretome on human blastocyst development was scored morphologically; and embryo secretions in response to EnSC cues analyzed by multiplex suspension bead immunoassay. Clonogenicity and induction of decidual marker genes were comparable between EnSC cultures from pregnant and non-pregnant group groups (P > 0.05). Analysis of 23 secreted factors revealed that successful implantation was associated with co-ordinated secretome changes in decidualizing EnSCs, which were most pronounced on Day 2 of differentiation: 17 differentially secreted proteins on Day 2 of decidualization relative to undifferentiated (Day 0) EnSCs (P < 0.05); 11 differentially secreted proteins on Day 8 relative to Day 2 (P < 0.05); and eight differentially secreted proteins on Day 8 relative to Day 0 (P < 0.05). By contrast, failed implantation was associated with a disordered secretome response. Blastocyst development was compromised when cultured for 24 h in medium conditioned by undifferentiated EnSCs when compared to decidualizing EnSCs. Analysis of the embryo microdroplets revealed that human blastocysts mount a secretory cytokine response to soluble decidual factors produced during the early (Day 2) but not late phase (Day 8) of differentiation. The embryo responses to secreted factors from decidualizing EnSCs were comparable between the pregnant and non-pregnant group (P > 0.05). Not applicable. Although this study uses primary EnSCs and human embryos, caution is warranted when extrapolating the results to the in vivo situation because of the correlative nature of the study and limited sample size. Our finding raises the prospect that endometrial analysis prior to ART could minimize the risk of treatment failure. This work was supported by funds from the Biomedical Research Unit in Reproductive Health, a joint initiative of the University Hospitals Coventry & Warwickshire NHS Trust and Warwick Medical School, the University of Nottingham and Nurture Fertility, and the National Medical Research Council, Singapore (NMRC/BNIG14NOV023), the “Instituut voor Innovatie door Wetenschap en Technologie” (IWT, Flanders, Belgium), the “Fonds voor Wetenschappelijk Onderzoek” (FWO, Flanders, Belgium) and the “Wetenschappelijk Fonds Willy Gepts” (WFWG, UZ Brussel). The authors have declared that no conflict of interest exists.

1 January 2008
Verified
Journal Article
Closed access
BRBarbara Rajtar
Barbara Rajtar
MMMagdalena Majek
Magdalena Majek
LPLukasz Polanski
Lukasz Polanski
Małgorzata Polz-DacewiczMałgorzata Polz-Dacewicz
Małgorzata Polz-Dacewicz

2 June 2014 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
LPL. T. Polanski
L. T. Polanski
MNM. A. Coelho Neto
M. A. Coelho Neto
CNC. O. Nastri
C. O. Nastri
PNPaula Andrea Navarro
Paula Andrea Navarro
RFR. A. Ferriani
R. A. Ferriani
WMW. P. Martins
W. P. Martins
Objective: To identify, appraise and summarize the available evidence regarding the effectiveness and safety of time‐lapse embryo monitoring on the main outcomes of assisted reproductive techniques.Methods: In this systematic review and meta‐analysis, we included only randomized controlled trials (RCTs) comparing time‐lapse embryo imaging with standard embryo monitoring. Our primary outcomes were live births (efficacy) and congenital abnormalities (safety). The secondary outcomes were clinical pregnancy, ongoing pregnancy and miscarriage.Results: Two RCTs were considered eligible, and their data were extracted and included in a meta‐analysis. In both studies embryos were transferred at the blastocyst stage. No studies reported rates of live birth or congenital abnormalities. Our estimates were not sufficiently precise to identify whether time‐lapse monitoring provided a small benefit, no effect or minor harm on rates of clinical pregnancy (relative risk (RR), 1.05 (95% CI, 0.80–1.38)) or ongoing pregnancy (RR, 1.05 (95% CI, 0.76–1.45)), based on two studies involving 138 women with moderate‐quality evidence. Considering the available data, we were unable to determine whether the intervention poses substantial benefit, no effect or substantial harm in the risk of miscarriage (RR, 0.95 (95% CI, 0.30–2.99)), based on two studies involving 76 clinical pregnancies with low‐quality evidence.Conclusions: Time‐lapse embryo imaging is unlikely to have a large effect on the chance of achieving clinical and/or ongoing pregnancy when transferring embryos at the blastocyst stage. More studies are required to improve the quality of the current evidence and also to examine whether this intervention is useful when transferring embryos at the cleavage stage. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.